MedImpact Healthcare Systems is providing access to two Humira biosimilars: Alvotech/Teva's Simlandi (adalimumab-ryvk) and Sandoz’s unbranded adalimumab-adaz. Beginning in January 2025, patients new ...
Some results have been hidden because they may be inaccessible to you